DE BARTOLOMEIS, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 9.624
NA - Nord America 7.903
EU - Europa 6.139
SA - Sud America 1.315
AF - Africa 279
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 25.270
Nazione #
US - Stati Uniti d'America 7.552
SG - Singapore 4.202
RU - Federazione Russa 2.687
CN - Cina 1.966
VN - Vietnam 1.637
IT - Italia 1.359
BR - Brasile 1.052
HK - Hong Kong 737
DE - Germania 428
FR - Francia 314
FI - Finlandia 254
BD - Bangladesh 243
GB - Regno Unito 199
NL - Olanda 198
CA - Canada 185
UA - Ucraina 178
IE - Irlanda 153
JP - Giappone 149
IN - India 115
KR - Corea 106
MX - Messico 101
CI - Costa d'Avorio 100
AR - Argentina 91
SE - Svezia 90
ES - Italia 62
IQ - Iraq 57
ZA - Sudafrica 56
ID - Indonesia 51
PL - Polonia 49
EC - Ecuador 48
PH - Filippine 44
TR - Turchia 44
AT - Austria 43
TH - Thailandia 40
PK - Pakistan 35
CO - Colombia 30
TW - Taiwan 30
MA - Marocco 26
VE - Venezuela 26
CL - Cile 21
AE - Emirati Arabi Uniti 19
JM - Giamaica 18
BE - Belgio 16
PY - Paraguay 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
LT - Lituania 15
PE - Perù 15
HU - Ungheria 14
EG - Egitto 13
JO - Giordania 13
KE - Kenya 12
MY - Malesia 12
TN - Tunisia 11
ET - Etiopia 10
IR - Iran 10
BG - Bulgaria 9
DZ - Algeria 9
IS - Islanda 8
UY - Uruguay 8
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
IL - Israele 7
KZ - Kazakistan 7
LB - Libano 7
GR - Grecia 6
KG - Kirghizistan 6
LA - Repubblica Popolare Democratica del Laos 6
NG - Nigeria 6
OM - Oman 6
SI - Slovenia 6
AL - Albania 5
AO - Angola 5
AU - Australia 5
AZ - Azerbaigian 5
CR - Costa Rica 5
HN - Honduras 5
NI - Nicaragua 5
NP - Nepal 5
PT - Portogallo 5
BO - Bolivia 4
BY - Bielorussia 4
CH - Svizzera 4
GE - Georgia 4
MN - Mongolia 4
QA - Qatar 4
RO - Romania 4
BS - Bahamas 3
BW - Botswana 3
CM - Camerun 3
CY - Cipro 3
GA - Gabon 3
GT - Guatemala 3
HR - Croazia 3
MK - Macedonia 3
NO - Norvegia 3
PA - Panama 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
Totale 25.201
Città #
Singapore 1.970
San Jose 1.570
Hong Kong 703
Moscow 669
Beijing 564
Ashburn 559
Ho Chi Minh City 444
Chandler 443
Hefei 419
Hanoi 384
Santa Clara 331
Naples 293
The Dalles 219
Lauterbourg 204
Millbury 204
Los Angeles 189
Jacksonville 179
Princeton 147
Amsterdam 142
Buffalo 118
Munich 118
Tokyo 118
New York 117
Nanjing 115
São Paulo 100
Boston 98
Houston 95
Rome 90
Wilmington 88
Redondo Beach 84
Norwalk 80
Dallas 79
Des Moines 76
Seoul 76
Frankfurt am Main 75
Da Nang 71
Haiphong 69
Seattle 67
Council Bluffs 65
Ottawa 62
Napoli 56
Turku 54
Milan 52
Nuremberg 52
Mexico City 50
Helsinki 49
Orem 47
Chicago 46
Nanchang 45
Brooklyn 44
Atlanta 41
Woodbridge 41
Denver 39
London 37
Lawrence 34
Montreal 34
Rio de Janeiro 33
Catania 32
Shenyang 31
Changsha 29
Falkenstein 29
Toronto 28
Hebei 27
Warsaw 27
Belo Horizonte 26
San Francisco 26
Chennai 25
Johannesburg 25
Biên Hòa 24
Dong Ket 24
Jiaxing 24
Phoenix 24
Hải Dương 22
Baghdad 21
Boardman 21
Stockholm 21
Can Tho 20
Falls Church 20
Kronberg 20
Brasília 19
Ankara 18
Poplar 18
Quito 18
Curitiba 17
Dhaka 17
Dublin 17
Lappeenranta 17
Bangkok 16
Düsseldorf 16
New Delhi 16
Portici 16
Salvador 16
Shanghai 16
Thái Nguyên 16
Bari 15
Tianjin 15
Barcelona 14
Brussels 14
Guangzhou 14
Ninh Bình 14
Totale 13.133
Nome #
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis “Nutra NMA SCZ” 217
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 203
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 188
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 185
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials 182
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 180
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 172
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 169
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 165
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 165
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 164
Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study 161
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 157
Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials 155
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations 154
Cognitive correlates of borderline intellectual functioning in borderline personality disorder 154
Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance 153
Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia 151
Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis 151
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach 150
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 149
Atypical depression and emotion dysregulation: Clinical and psychopathological features 147
Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice 147
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 146
Transcranial direct current stimulation for obsessive–compulsive disorder: A randomized, controlled, partial crossover trial 146
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 146
Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis 143
Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study 142
Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia 142
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings 141
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 141
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 138
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 137
Depression and Anxiety Symptoms "Among the Waves" of the COVID-19 Pandemic in Obsessive Compulsive Disorder and Adjustment Disorder Patients 135
Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia 135
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 135
Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine 134
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 133
Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors 133
Psychiatric Symptoms in Parkinson’s Disease Patients before and One Year after Subthalamic Nucleus Deep Brain Stimulation Therapy: Role of Lead Positioning and Not of Total Electrical Energy Delivered 132
Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia. 132
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 130
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 130
The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications 130
Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal 129
Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction 129
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 129
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment 129
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 128
Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study 128
Acute administration of antipsychotics modulates Homer striatal gene expression differentially 127
Homelessness and health-related outcomes: an umbrella review of observational studies and randomized controlled trials 126
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 126
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 126
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 126
Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor 125
The Role of Astrocytes in the Molecular Pathophysiology of Schizophrenia: Between Neurodevelopment and Neurodegeneration 125
Perinatal stress modulates glutamatergic functional connectivity: A post-synaptic density immediate early gene-based network analysis 124
Mental health during the 2022 Russo-Ukrainian War: A scoping review and unmet needs 124
The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials 123
d-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice 123
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 123
Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder 123
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 123
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 123
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis 122
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 122
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 122
The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted 122
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications 122
Corrigendum to “Exploring clinical phenotypes of food addiction and its distress correlates: A cross-sectional evaluation in treatment-seeking individuals with obesity” [Eating Behaviors volume 57 (April 2025), Online ahead of print, 101961] 121
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review 121
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 121
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 121
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 121
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia 120
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 120
A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration 120
Severity of autism-related symptoms in treatment-resistant schizophrenia: associations with cognitive performance, psychosocial functioning, and neurological soft signs - Clinical evidence and ROC analysis 119
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia 119
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 119
Prominent autistic traits and subthreshold bipolar/mixed features of depression in severe anorexia nervosa 119
Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates 118
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation 118
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention 118
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 117
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 117
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis 116
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 116
Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins 116
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 116
Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials 115
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment 115
Effects of strict COVID-19 lockdown on patients with obsessive-compulsive disorder compared to a clinical and a nonclinical sample 115
Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis 114
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 114
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 114
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 114
Dandy-Walker Syndrome with psychotic symptoms: A case report 114
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia 113
Totale 13.470
Categoria #
all - tutte 81.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022971 14 1 8 11 8 48 22 32 162 79 163 423
2022/20231.187 193 95 35 49 138 160 14 108 159 103 89 44
2023/20241.016 33 146 92 92 59 51 60 161 35 26 168 93
2024/20256.460 322 423 16 55 170 320 717 444 487 653 2.222 631
2025/202613.692 1.487 1.048 1.444 1.050 2.208 512 1.641 726 1.658 923 438 557
2026/2027227 227 0 0 0 0 0 0 0 0 0 0 0
Totale 25.644